Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mason, E. O.
Right arrow Articles by Ambrose, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, E. O., Jr
Right arrow Articles by Ambrose, P. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 623-631
© 2000 The British Society for Antimicrobial Chemotherapy

Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis

Edward O. Mason, Jra,b,c,*, Linda B. Lamberthc, Nerisa L. Kershawa,b,c, Barbara La T. Prosserd, Annette Zoed and Paul G. Ambrosed

a Departments of Pediatrics, b Microbiology and Immunology, Baylor College of Medicine, c Infectious Disease Laboratory, Texas Children's Hospital, Houston, TX 77030; d Bristol–Myers Squibb, Plainsboro, NJ 08536, USA

Ninety-two laboratories in the USA submitted isolates of Streptococcus pneumoniae to a single laboratory for susceptibility testing. Overall, 64% of 4489 isolates were susceptible to penicillin, 24% were intermediate and 13% were resistant to penicillin, although susceptibilities varied depending on geographical region. Macrolide/azalide resistance varied from 4 to 30%, with some regions having macrolide/azalide resistance higher than penicillin resistance. Children 12 years of age were significantly more likely to be infected with a penicillin-resistant pneumococcus than were adolescents or adults. Isolates from the respiratory tract were more likely to be penicillin resistant and >50% of pneumococci from the ear were resistant to penicillin. Almost 25% of penicillin-susceptible isolates had cefaclor MICs 2.0 mg/L and 15% of penicillin-susceptible isolates had loracarbef MICs 2.0 mg/L. These isolates would be erroneously reported as susceptible using NCCLS guidelines, and this finding may explain the lack of clinical response in patients treated with these antibiotics. The predicted plasma concentrations of all cephalosporins tested exceeded the geometric mean MIC for at least 40% of the dosing interval for penicillin-susceptible S. pneumoniae; for penicillin-intermediate S. pneumoniae, only cefprozil (56%), cefuroxime (64%) and cefpodoxime (63%) reached >40% of time above the geometric mean MIC in the dosing interval. None of the cephalosporins evaluated achieved a substantial time above the geometric mean MIC during its dosing interval for fully penicillin-resistant S. pneumoniae.

* Correspondence address. Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. Tel: +1-713-770-4330; Fax: +1-713-770-4347; E-mail: emason{at}bcm.tmc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
J. B. Bulitta, C. B. Landersdorfer, M. Kinzig, U. Holzgrabe, and F. Sorgel
New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics
Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3462 - 3471.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Smith, L. M. Ednie, P. C. Appelbaum, S. Hawser, and S. Lociuro
Antistreptococcal Activity of AR-709 Compared to That of Other Agents
Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2279 - 2282.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
V. Matic, K. Kosowska, B. Bozdogan, L. M. Kelly, K. Smith, L. M. Ednie, G. Lin, K. L. Credito, C. L. Clark, P. McGhee, et al.
Antipneumococcal Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Erythromycin, Azithromycin, Clarithromycin, Clindamycin, and Telithromycin
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4103 - 4112.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. R. Jacobs, D. Felmingham, P. C. Appelbaum, R. N. Gruneberg, and the Alexander Project Group
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
J. Antimicrob. Chemother., August 1, 2003; 52(2): 229 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Bingen, C. Doit, C. Loukil, N. Brahimi, P. Bidet, D. Deforche, and P. Geslin
Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2345 - 2347.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. A. Preston, M. R. Turnak, M. R. Jacobs, P. C. Appelbaum, G. G. Zhanel, D. E. Low, and W. Craig
Assumed versus Approved Breakpoints
Antimicrob. Agents Chemother., November 1, 2000; 44(11): 3243 - 3245.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.